At Fractyl, we’re focused on pioneering a new way to address root causes of serious metabolic diseases like obesity and type 2 diabetes: in the gut. Our goal is to transform the metabolic disease treatment paradigm—from chronic symptomatic disease management to durable, disease-modifying therapies that aim to solve obesity and type 2 diabetes, for good.

We have assembled a mission-driven team of innovators and experts, all united in their passion to develop breakthrough therapies—the type of therapies we would want for ourselves and our loved ones with these diseases.